Category Archives: Chemicals


The Women’s Enterprise Forum Serves as a Strategic Advisor to the Women’s Business Enterprise National Council

Wilmington, DE, 2018-Mar-15 — /REAL TIME PRESS RELEASE/ — Peggy Del Fabbro, CEO of M. Davis and Sons, Inc. has been appointed to 2nd Vice Chair of the Women’s Enterprise Forum, which serves on an advisory capacity for the Women’s Business Enterprise National Council (WBENC), the nation’s largest certifier of women-owned businesses and leader in women’s business development.

The Women’s Enterprise Forum provides opportunities for WBENC-Certified Women’s Business Enterprises (WBEs) to represent the voice of all women’s business enterprises and engage in networking and development activities with other WBEs, member corporations and government entities.

As 2nd Vice Chair of the Women’s Enterprise Forum, Peggy will assist in leading the Forum’s primary initiatives to provide input and feedback on WBENC programs and other matters at the direction of the WBENC Board of Directors. A leader in her company and in her community, Peggy values the opportunity to be involved with WBENC at a national level.

To learn more about the Women’s Enterprise Forum, visit

WBENC is the largest third-party certifier of businesses owned, controlled, and operated by women in the United States. WBENC partners with 14 Regional Partner Organizations (RPOs) to provide its world-class standard of certification to women-owned businesses throughout the country. WBENC is also the nation’s leading advocate of women-owned businesses and entrepreneurs. Throughout the year, WBENC provides business development opportunities for member corporations, government agencies and more than 14,000 certified women-owned businesses at events and other forums. Learn more at

About M. Davis & Sons, Inc.
M. Davis & Sons, Inc. is a fifth generation women-owned industrial contractor and fabricator located in Delaware that has served customers for more than 145 years in the oil & gas, chemical, pharmaceutical, food, beverage and industrial markets.

Media Contact:

Elaine Buonopane
M. Davis and Sons, Inc.
19 Germay Drive, Wilmington, DE 19804
Phone Number: 302-993-3365,

Innovative Drug Discovery Business, Biosortia Pharmaceuticals, Lands Two Health Care Veterans

Kurt Dieck formerly SVP of Strategy and Business Execution at Cardinal Health, will lead early stage drug discovery business at Biosortia Pharmaceuticals. Dieck was named President and CEO in November 2012 and has quickly identified other key executives, including Dr. Guy Carter, former Natural Product head at Wyeth Pharmaceuticals, as his Chief Science Officer. In conjunction, other collaboration partners have joined the team, including NOAA (National Oceanic and Atmospheric Administration), NCI (National Cancer Institute) and key universities, to strategically accelerate the development of novel drug leads in the therapeutic areas of cancer, infectious diseases, inflammation and neurological disorders. Biosortia Pharmaceuticals has seen promising early results with dozens of novel compounds having already been requested, and are under evaluation with NCI and Eli Lilly.

Dieck has spent nearly 30 years in healthcare, including 18 years at Arthur Andersen as a global equity partner and then 10 years with Cardinal Health, a Fortune 20 public company, as a senior executive; there he worked with a broad spectrum of partners, including brand pharmaceutical manufacturers, throughout the supply chain. Dr. Guy Carter has over 30 years of experience working in pharmaceutical R&D, primarily in the discovery and development of microbial natural products. He previously was the leader of natural products drug discovery at Wyeth Research, as head of the Chemical Technologies Department.

“Kurt and Guy make a great team. Their complementary Pharma experiences and backgrounds create great opportunities to accelerate Biosortia’s objective to become the premier, aquatic natural products company with a primary focus in drug discovery,” says Ross Youngs, Biosortia’s Founder and Chairman. “Kurt and Guy bring a wealth of research and business experience along with deep industry relationships in building successful Pharma partnerships. Everyone involved with this young biotech is excited about the future.”

Industry observers have commented that late-stage R&D pipelines are not providing Pharma with the desired revenue growth the market is expecting. Therefore, large Pharma is evolving the way it performs R&D in order to optimize efficiency and to boost patent cliff defenses. These changes require shifting from relying solely on in-house chemistry-based R&D to acquiring and licensing external technologies and natural products based compounds in various stages of development. Biosortia’s ability to supply novel, highly active and potent compounds with drug-like characteristics will increase the productivity and success rate for Pharma as well as reduce the overall cost of the discovery process. The cost to discover, develop and launch a new drug is estimated to reach nearly $3B per drug by 2015. Biosortia’s business model is designed specifically to support Pharma’s needs.

“With nearly unlimited microorganisms (3.7 nonillion), the aquatic environment and its consortia represent an extraordinary opportunity…a new frontier, to access extremely potent and chemically diverse secondary metabolites with drug-like properties with unique mechanisms of action never researched before,” said Dieck. In describing the opportunity, Dieck goes on to say, “Biosortia is on the cutting edge of natural product discovery
and has the capabilities to deliver on its aspiration. Our powerful natural products research team, led by Dr. Guy Carter, in partnership with NOAA’s Dr. Peter Moeller, a leader in aquatic natural products research, has the experience and know-how to decipher the complex unexplored environment in a very efficient manner leveraging all the current state of the art instrumentation. The need for more efficient and effective approaches to drug discovery has never been more important. Biosortia’s innovative technologies, deep research skills and key relationships will efficiently provide thousands of unique natural products as candidates for drug discovery at a time when Pharma is in critical need for “high quality shots on goal.”

“Aquatic microbial consortia are a rich source of metabolically active organisms including microalgae, bacteria, fungi and their secondary metabolites,” states Carter. “Owing to the competitive nature of their habitat, chemical investigations of microbial consortia reveal unique structurally diversified natural products that are responsible for signaling and self-defense that have potential as therapeutics with novel mechanisms of action. Since they have been pre-optimized by nature, these compounds are typically closer to a drug candidate than a synthetic lead, thus requiring less optimization and shorter time when found as ‘hits’ in screening programs.”

The team has also focused on agreements with strategic collaboration partners as vital components to the strategy. Biosortia has recently entered into several collaboration agreements with NOAA, Analyticon and exclusive harvesting relationships, just to name a few. Several others will be advanced by the end of January. Biosortia’s cooperative research and development agreement (CRADA) with NOAA’s Center for Human Health Risk at Hollings Marine Laboratory provides a 5-year framework for research and development regarding the analysis and purification of novel bioactive compounds. According to NOAA’s Technology Partnerships Office, “Success will result in the commercial development of new and unique chemical compounds from the sea which have benefits to human health, either through disease prevention or new treatments for disease.”

Dr. Peter Moeller, NOAA’s Research Scientist who leads the Toxins Natural Products Program stated after analyzing fractions of Biosortia’s biomass, “Coupling NOAA’s mission of characterizing toxins affecting environmental and/or human health with Biosortia’s drug discovery focus turns one man’s toxin into another’s chemotherapeutic. The microorganisms analyzed in the Biosortia biomass identified more unique activity than I have seen in my 30 year career. The volumes achieved from a single harvest delivered an equivalent of 30 years of accumulation. This could materially change the landscape for natural products drug discovery research.”

As of December 31, 2012, Biosortia has identified more than 30 bioactive candidate compounds (hits) from a fresh water eutrophic lake consortium. Therapeutic areas of focus include treatments for cancer, infectious diseases, inflammation and neurological disorders. In addition, more than a dozen of its patent protected compounds are in initial evaluation stage within Eli Lilly’s Open Innovation Drug Discovery Program.

Dieck states, “Looking forward, it is with great optimism. We have a great team built around mutual respect, deep experience, and a desire to succeed and make a difference. We are aligning with the right partners and collaborators to execute our strategy with speed and discipline to provide Pharma with much high quality & diverse compounds vs. “me-too” drugs than they have had in the past 10 years. We are excited about what this company can accomplish, not only for its shareholders but also for the millions of people who have been diagnosed with various forms of chronic diseases who are looking for Pharma to identify better ways to help them extend their lives or live a more productive life. Biosortia can play a big role in identifying compounds that can help Pharma achieve these goals. I am looking forward to the challenge and opportunity to build an industry leading drug discovery company.”

# # #

About Biosortia Pharmaceuticals Biosortia Pharmaceuticals is a division of Algaeventure Systems (AVS). AVS is privately held company and are the inventors of the biomass harvesting technology. Biosortia has a proven and unique ability to obtain unculturable aquatic microorganism consortia from the natural environment in unprecedented quantities that allows its research team to perform direct study of vast quantities of new natural products (NPs), the foundation of most anti-infective agents such as antibiotics for the treatment of bacterial infections. Over 76% of cancer drugs are derived in some manner from NP.

If you’d like more information about the announcement or the company or to schedule an interview with Kurt Dieck, please call:

David Coho
Tel. 614-636-4850
Cell Phone: 614-325-9804


Safeline Unveils HACCP Metal Detector with Modern Technology for Food Safety Standards in India

Mumbai, 25th February 2012: With ISO 22000 is set to become the global HACCP based international food safety standard, Mettler-Toledo Safeline, the leader in the field of industrial metal detection solutions, unveils its latest range of Profile metal detectors in India. The company offers the most advanced range of metal detection equipment in the world with a solution for every application.


Available in rectangular apertures for conveyorised applications, the “Profile” range is available in fixed, dual or multi and Selectable frequency configurations. The “Profile LS” variant of the range offers customers the freedom of choice to select the level of functionality required to suit their actual requirements. This is achieved through the selection of optional software which is designed to address specific business functions. The range is further complimented by the release of a new Profile ASN model which is designed to address applications where installation space is restricted. This comprehensive portfolio ensures that whatever the application, there is a Profile metal detection solution available.


Detection sensitivity levels have been enhanced to new heights with the development of a new software algorithm that significantly reduces the impact of signals present in the environment whilst simultaneously minimising the size of the signal (known as the product effect) given off by the product being inspected. The use of intelligent multi-channel technology also improves detection capability to a level previously unachievable.


Whilst sensitivity is the measure of metal detection performance, further customer focussed features have been developed to make the Profile an integral part of a user’s effective contamination prevention programme.


Ensuring compliance is achieved through meeting the demands of a HACCP programme, helping to increase on-line productivity, ensuring uptime is maximised and reducing costs are all key fundamental elements for food producers.


A unique Condition Monitoring system monitors key elements of the Profile metal detectors functionality and works on the basis that prevention is better than cure especially when measured against the costs of downtime. Many metal detectors in use today are designated as Critical Control Points (CCP’s). Should a problem occur with the metal detector during the inspection process, the production line should shut down until the problem is rectified as the CCP is no longer protected.


The cost associated with a line shutdown can be high. A metal detector that can advise when a fault occurs can be seen as beneficial as it allows for emergency service to be undertaken. However a metal detector that can give an advanced warning that a fault may be about to occur before it happens allows preventative maintenance to be scheduled when the line is out of service saving time and money.


“In order to maximize on quality and performance, METTLER TOLEDO has brought the unparallel metal detection solution, Profile Series, utilizing sophisticated software technology, Profile Series is very helpful in complying HACCP requirements and also for broader needs of External Food Safety regulations. Whether your products are wet, dry, hot, chilled or frozen, Profile Technology provides the ultimate solution in metal contaminant detection capability.” said Kailash Kale, Business Leader – Product Inspection. “All metal contamination including ferrous, non-ferrous and even the most difficult to detect non-magnetic stainless steels are readily identified, enabling them to be removed efficiently from the manufacturing process. Profile detectors in real sense provide a vital building block in helping the customers to establish improved processes and manufacturing efficiency thus increase productivity, to ensure uptime is maximized and also to reduce costly downtime.”


Continuing on the theme of maximising production uptime, Profile has been developed to address one of the biggest reported failure modes of any process or packing line equipment – that of operator error or unauthorised entry to the controls of equipment.


To address this issue, a secure personalised login system that allocates every user their personalised entry password has been created. To help navigation around the menu structure, operators can specify their own settings in a choice of 18 languages to ensure that when they log on, they can quickly and easily identify the operations they have been given access to. Every login to the detector is stored in an access log that can be viewed on the colour touch screen which reports the name of the operator and date and time when they logged onto the controls. This provides far greater levels of traceability and system security.


Using the latest in communications technology, Profile detectors can be configured to send email or text communications to various key people within the business reporting important events or issues. These could include missed performance verification tests, early warnings from the Condition Monitoring system.


It is even possible to configure the detector to communicate directly with Mettler Toledo service organisations to allow the fastest levels of response possible.



About Mettler-Toledo Safeline:


Mettler Toledo Safeline is the world’s leading supplier of metal detection and x-ray inspection solutions for the food and pharmaceutical industries. Together with Garvens Checkweighing, Mettler-Toledo Safeline forms the Product Inspection division of Mettler Toledo.

About Mettler-Toledo India:

Mettler-Toledo India Pvt. Ltd., a wholly subsidiary of Mettler-Toledo Inc. (NYSEMTD), started its operations in India in 1998. With its base in Mumbai and eleven branches across India, Mettler-Toledo India is a leading player catering to the demand of Indian industries for high-technology precision and analytical instruments used in various labs and automation processes.


Mettler-Toledo inc is a leading global supplier of precision instruments and is the world’s largest manufacturer and marketer of weighing instruments for use in laboratory, industrial and food retailing applications. The Company also holds top-three market positions in several related analytical instruments markets and is a leading provider of automated chemistry systems used in drug and chemical compound discovery and development. In addition, the Mettler-Toledo is the world’s largest manufacturer and marketer of metal detection systems used in production and packaging. Additional information about Mettler-Toledo can be found on its website




For more details, contact:

Sanjiv Arora
Deesha Communications

Making Waves in Research Labs Around the World

Buy Research Chemicals, the market leaders in supplying innovative research chemical compounds to scientists based in the European Union, as well as research institutes and chemistry students. Providing only the highest quality chemicals specifically made for research purposes, scientists can now access the range of etizolam pellets and methiopropamine.

A chemical only sold by a select number of genuine suppliers, methiopropamine has recently acquired a new range of fans, with the chemical proving particularly popular as a research subject for laboratory research. At present there are very few compiled reports about the substance, which is why it is an exciting time to be associated with it.


Similarly, Etizolam Pellets are also causing a stir in the research fields, enabling scientists to accurately gauge how much material they are deploying into their experiments thanks to their pellet form. Just like methiopropamine, there is currently very little information available to the public and professionals regarding the chemical, but what we are aware of is that it is structurally related to benzodiazepines such as Valium and Xanax, with a few key differences.


Just as exciting is the offer currently available on the site relating to 3.5g Haze orders, by which Buy Research Chemicals are throwing in ten 1mg etizolam pellets for free with 7g orders of Haze, or 40 pellets with 28g orders, giving you more scope for your research without the extra cost.


As with everything available on the exciting Buy Research Chemicals website, neither Methiopropamine nor etizolam pellets are approved for in-vivo research, meaning it is not suitable for use with humans or animals, or for clinical trials.


If either substance is accidently ingested into the body of a human or animal, medical attention should be sought immediately.


It is also crucial that you are fully aware of how much you are testing in your research, making sure that you are dealing with safe amounts and that you are not allergic to any of the ingredients you may find yourself coming into contact with.


Buy Research Chemicals are tried and tested suppliers of all the research projects available on the site and as such are a trusted source for all of your scientific requirements. By coming to BRC, you can be assured that you are getting the exact product that you require, as opposed to a chemical that has been contaminated by something else, which, obviously, will corrupt the data acquired during any research undertaken in the laboratories.


For more information visit:


Buy Research Chemicals

145-157 St John’s Street




0845 388 0093

Advanced Liquid Logic Licenses Patents, Creates Collaboration With CEA-Leti

RESEARCH TRIANGLE PARK, NC, SEPTEMBER, 27 2011 – Advanced Liquid Logic announced today that it has signed a license and collaboration agreement with the French research institute CEA-Leti. The agreement provides Advanced Liquid Logic with worldwide exclusive access to CEA’s portfolio of patents related to digital microfluidics.

Advanced Liquid Logic co-founder and Dr. Michael Pollack said, “This agreement puts our company in a clearly dominant position with respect to the intellectual property surrounding digital microfluidics.” Co-founder Dr. Vamsee Pamula added, “the accompanying collaboration with a very active and highly competent group of researchers will provide us with key technical resources to help address both today’s and tomorrow’s technology challenges.” Advanced Liquid Logic has set up a subsidiary company in Grenoble, France to help manage the collaboration and to provide an initial position to address market opportunities in Europe. CEA-Leti employee Dr. Cyril Delattre will join the company and manage Advanced Liquid Logic’s French subsidiary.
“The combination of Advanced Liquid Logic’s intellectual property position and their readiness for market made them the ideal partner,” said Dr. Laurent Malier, CEO Leti. “We expect that our complementary skills, expertise and intellectual property will be very useful going forward. This partnership with Advanced Liquid Logic offers an industrial solution that will help us develop applications bases on microfluidics for many sectors”.

Advanced Liquid Logic previously acquired intellectual property from Nanolytics and Core Microsolutions. The company now owns or controls over 45 issued patents related to their proprietary, electrowetting-based digital microfluidic technology.

About Advanced Liquid Logic
Advanced Liquid Logic, headquartered in Research Triangle Park, North Carolina, is commercializing its proprietary “Digital Microfluidics” technology in a spectrum of life sciences and clinical diagnostics applications. Digital microfluidics enables precise and flexible manipulation of microdroplets using electrical fields and therefore avoids the need for pumps, valves or microchannels required by competing technologies. For more information please visit

Richard West
+1 919 287-9010

About CEA-Leti
CEA is a French research and technology organization, with activities in four main areas: energy, information technologies, healthcare technologies and defence and security. Within CEA, the Laboratory for Electronics & Information Technology (CEA-Leti) works with companies in order to increase their competitiveness through technological innovation and transfers. CEA-Leti is focused on micro and nanotechnologies and their applications, from wireless devices and systems, to biology and healthcare or photonics. Nanoelectronics and microsystems (MEMS) are at the core of its activities. As a major player in MINATEC campus, CEA-Leti operates 8,000-m² state-of-the-art clean rooms, on 24/7 mode, on 200mm and 300mm wafer standards. With 1,400 employees, CEA-Leti trains more than 190 Ph.D. students and hosts 200 assignees from partner companies. Strongly committed to the creation of value for the industry, CEA-Leti puts a strong emphasis on intellectual property and owns more than 1,700 patent families.

Thierry Bosc
+33 4 38 78 31 95



Enabling microRNA Discoveries – 250th Peer-Reviewed Publication Made Possible By µparaflo Custom Microarray Technology

Jun 09 2011 /RTPR/ – LC Sciences, a life sciences company leading the development of innovative microRNA (miRNA) analysis and discovery technologies, announced today the publication of over 250 peer-reviewed studies using the company’s microarray service for analyzing miRNA expression profiles. These studies, by leading researchers in the field, represent significant steps toward realizing these small regulatory RNA’s potential as biomarkers and therapeutic targets.

MiRNAs have proven to be an extremely important part of the gene expression regulation mechanism of a wide variety of cellular processes. This is evident in the amount of relevant findings by LC Sciences’ customers being translated into published reports and the diverse range of study areas that these publications encompass: cancer research, neuroscience, cardiovascular research, reproductive biology, plant science, microbiology, immunology and stem cell research. LC Sciences’ miRNA profiling service, powered by its µParaflo® custom microarray technology, provides quick, reliable, fully analyzed datasets enabling researchers to immediately move forward with groundbreaking research.

The miRNA field is still nascent, and it is advancing rapidly. The race to discovery has produced a continuous stream of new miRNA sequences as well as routine revisions of inaccurate or incomplete sequences. This fluidity has caused many microarrays with static content to fall away and has fueled reports of the wholesale replacement of microarrays by new methods such as RNA-Seq. But the nimble, customizable format of the µParaflo® array has given it staying power, not only by enabling it to keep current with all known miRNAs, but also by making use of data generated by RNA-Seq. These custom arrays have benefited from RNA-sequencing generating novel content that other arrays are unable to capture and take advantage of.

The 250th study, entitled “Wolbachia uses host microRNAs to manipulate host gene expression and facilitate colonization of the dengue vector Aedes aegypti.” appeared in the May 31st issue of PNAS and was one of a group of articles published recently by LC Sciences’ customers describing microarray expression analysis of miRNAs recently discovered through RNA Sequencing.

Researchers at the University of Queensland, Australia studied the underlying mechanisms of host manipulation by a widespread endosymbiont. Using microarrays, they show that the miRNA profile of the mosquito, Aedes aegypti, is significantly altered by a life-shortening strain of W. pipientis bacteria. This is extremely important work as introduction of Wolbachia into mosquitoes has been proposed as a method for malaria control. They found that a host miRNA (aae-miR-2940) is induced after W. pipientis infection in both mosquitoes and cell lines.

This study illustrates the versatility of µParaflo® from a couple of perspectives. First, mosquito, an important though non-model species was the target of interest here and mosquito arrays, as well as arrays from any of the 153 species listed in the miRBase public sequence database, are readily available from LC Sciences. Second, custom content (novel miRNA sequences from an earlier sequencing study on the same species) was quickly integrated into the content of the insect array providing an even richer expression dataset. Though all the previously described, known insect miRNAs were also present on the arrays, several custom sequences were significantly differentially expressed in infected mosquitoes and a custom sequence turned out to be one that became a focus of the investigation. Dr. Sassan Asgari, lead researcher for the study, commented that microarrays “…provided an affordable approach to the study of differential expression of small RNAs and miRNAs in particular.”

“We are very excited about the announcement of the 250th peer-viewed publication by one of our microarray customers,” says Chris Hebel, VP of Business Development at LC Sciences. “We were the first to provide a microarray expression profiling service for miRNA back in 2005 and proud to be still going strong in the face of rapidly advancing technologies, while many other less adaptable arrays, have fallen away. Despite the apparent advantages of new technologies such as RNA-Seq, microarrays have been the gene expression workhorse for many years and continue to be a robust, affordable solution. High-throughput RNA sequencing is still significantly more expensive and it won’t be until there is sufficient multiplexing of samples when we finally do reach a cost approaching that of microarrays. Of course more samples means less coverage per sample, and I think we’re still trying to figure out just how much coverage is required for robust expression data from deep sequencing and therefore what level of multiplexing can ultimately be reached. Meanwhile, RNA-Seq has become an amazing tool for discovery of novel miRNAs and continues to provide new content for our custom microarrays.”

About µParaflo® Technology – The µParaflo® technology is a microfluidic platform for in situ parallel synthesis of biomolecular chips and miniaturization of bioassays including hybridization, binding and enzymatic reactions. This unique platform technology is based on pico-liter microfluidic reaction devices and a digital light controlled synthesis method that employs conventional oligonucleotide or peptide synthesis chemistry; a completely programmable process. The seamless integration of these multidisciplinary technologies enables a significant advance in
parallelization, miniaturization, customization, and automation.

About LC Sciences – LC Sciences offers discovery, profiling and validation services for microRNA and other small RNAs. Services include deep sequencing for discovery applications, microarrays for differential expression profiling and validation/confirmation of newly discovered microRNAs, and qRT-PCR for quantitation of microRNA expression levels. These comprehensive services are designed to be one-stop and produce the results needed to quickly advance your biological and biomedical research. Combining the latest deep sequencing technology with ourµParaflo® on chip synthesis technology offers unprecedented flexibility and customization capability.

More information about LC Sciences is available at

Hussain M, Frentiu FD, Moreira LA, O’Neill SL, Asgari S. (2011) Wolbachia uses host microRNAs to manipulate host gene expression and facilitate colonization of the dengue vector Aedes aegypti. Proc Natl Acad Sci USA 108(22), 9250-55.

Contact Details: Chris Hebel
LC Sciences LLC
2575 West Bellfort St, Ste 270
Houston, TX 77054
FAX 713-664-8181


EPA-registered and USDA-Certified Organic Pesticides Now Available for Licensing

An agribusiness licensing company, Verde Bio-Science, has added a line of patent-pending EPA-registered and USDA-certified organic products available for licensing by others.

The newly-added organic line includes multiple insecticides and herbicides, plus a fungicide, miticide, horticultural oil, and several repellents.   The eleven new products bring the company’s total list of product registrations available for licensing to 438.

“We are pleased to add these EPA-registered and USDA-certified organic products to our license offering,” said Jeff Elliott, Executive Vice President of Sales for Verde Bio Science. “We receive numerous requests for licenses for certified organic products; these new inputs will make a number of our clients very happy.”

Verde Bio-Science, a DBA of Custom Chemicides, licenses companies to manufacture, sell, and distribute its agricultural and horticulture products through its patent-pending Smart Licensing Program.

“Our licensing program brings together people, companies, and products from various pesticide and fertilizer industries,” said Elliott. “On one side of the business, we work with scientists, labs, chemists, corporations, and even bench-shop chemists who have patented, patent-pending, and post-patent ag products they want to license to others.”

“On the other side of our business, we have clients who purchase licenses from us allowing them to begin manufacturing the products almost instantaneously.  Purchasing a license satisfies their immediate need for the product, and eliminates the costly multi-year effort of registering the chemical, conducting test trials, and gathering crop data.

“Our clients have saved a great deal of time, money, and aggravation by purchasing licenses for the exact products they need, as well as opening whole new lines of business for their company.”

Verde Bio-Science also offers full turn-key business packages ranging from chemical manufacturing facility development and set-up, to the hiring of a sales force for those newly entering the ag industry.

Diane Tjerrild,
Cell: (559) 696-6553,


APT and Mitsui Chemicals Europe Enter Into New Distribution Agreement For Milastomer

Advanced Polymer Trading FZC has partnered with Mitsui Chemicals to market, sell and distribute Milastomer, Mitsui’s Thermoplastic Olefinic Elastomer.

Advanced Polymer Trading (APT), an international trading company specialising in the world wide trade of rubber, plastics and petrochemicals, has entered into an agreement with Mitsui Chemicals Europe to market, sell and distribute Mitsui’s Thermoplastic Olefinic Elastomer under the Milastomer brand.

As part of the Mitsui Chemicals Group, Mitsui Chemicals Europe serves the European, Middle East and African markets which are the sectors and markets targeted by APT. Its headquarters are in Dusseldorf which is home to the biggest Japanese community in Europe.

“Mitsui’s Milastomer is a first class Thermoplastic Olefinic Elastomer” said Mr. Hamid Amiri, APT’s Managing Director. “We are very pleased with this new agreement which builds on our existing partnership with Mitsui.”

Milastomer, which is particularly suited for the automotive industry where it is used for interior trims including dash boards, doors and headliners, is based on Mitsui’s years of expertise and experience in plastics and synthetic rubber manufacturing. Unlike traditional rubber, Milastomer does not need compounding or vulcanization by the end user and every grade of Milastomer can be molded or extruded similar to polyethylene and polypropylene. Also like PVC, Milastomer has excellent moldability when processed on calendering machines.

About Advanced Polymer Trading FZC

Advanced Polymer Trading FZC (APT) is an international trading company in plastic, rubber and chemicals serving a diverse range of industries including the automotive industry, packaging industry, construction, road and building material sectors, paint, resin and adhesive industries, pipe, medical, agriculture and the shoe & leather industries.


Advanced Polymer Trading FZC

19th Floor, Festival Tower
Dubai Festival City
Dubai – UAE

Tel: +971 4 293 2608
Fax: +971 4 293 2525

Website :


Press Contact:

ArtSec Group

Media & Publishing Division ( – +1 817 224 2231

Onondaga Nation and Brooklyn-based Ecologic Solutions Announce Green Partnership

MAR 31, 2011 /RTPR/ — Brooklyn, NY — Onondaga Nation and Brooklyn-based Ecologic Solutions today announced a historic, Native American-green business partnership to boost the company’s efforts to rid workplaces of toxic cleaners and replace them with sustainable alternatives.

Under the terms of the partnership, Onondaga Nation ( has agreed to become the second largest shareholder in EcoLogic Solutions (, a leading supplier of natural, plant-based cleaning supplies for restaurants, hotels, schools, office buildings, and other commercial users. EcoLogic Solutions will use the investment to create jobs and expand current operations, while developing new products and approaches to eliminate harmful cleaning supplies from workplaces.

“EcoLogic Solutions is a company that shares our goals of a more sustainable planet, and a better, more holistic way of doing business,” said Jake Edwards, member of the Onondaga Nation Council of Chiefs. “This is the first time we’ve invested in a U.S.-based environmental firm. When you partner with Onondaga, you partner for life.”

“When I founded EcoLogic Solutions, I looked to Onondaga values and sustainability as paragons for our business,” said EcoLogic CEO Anselm Doering. “That’s why I’m honored, and humbled, to make in this announcement today. It’s the fulfillment of a dream within a dream.”

Based in the Brooklyn Navy Yard along with 30 other green businesses, EcoLogic Solutions manufactures soaps, detergents, degreasers, solvents, glass cleaners, disinfectants, and other earth-friendly cleaning supplies for the institutional marketplace using bio-based formulations that are readily biodegradable and non toxic to humans and aquatic life. The company, using groundbreaking technology and scientific advances, offers the most progressive, environmentally preferable commercial cleaners in the market today.

EcoLogic Solutions clients include Chipotle Mexican Grill, Whole Foods Markets, the Statue of Liberty, Mandarin Oriental Hotels, Mario Batali & Bastianich Hospitality Group, the Durst Organization, and NBC Universal, among many others. It sells exclusively to wholesale markets at this time. EcoLogic Solutions’ products will be made available to Onondaga Nation citizens soon.

A sovereign nation on 7,300 acres south of Syracuse, Onondaga is a proud member of the Haudenosaunee (“People of the Long House”), an alliance of six Native American nations sometimes referred to as the Iroquois Confederacy or Six Nations. Other members include the Mohawk, Oneida, Cayuga, Seneca, and Tuscarora nations.

“The Onondaga Nation and its people have a unique spiritual, cultural, and historic relationship with the earth and the waters, which is embodied in
Gayanashagowa, the Great Law of Peace,” said Jake Edwards. “It is the duty of the Nation’s leaders to work for a healing of the earth, to protect it and pass it on to future generations. This partnership is about making a better world for the generations yet to come.”


Contact Details:

EcoLogic Solutions
63 Flushing Ave Unit 267
Brooklyn NY 11205

Franz Wisner,, 800-477-2577

Anselm Doering,, 917-805-3007

Jake Edwards, Onondaga Nation,, 315-952-0412


Advanced Polymer Trading Launches New Web Site; Improves on Performance, Information and Accessibility

Reflecting its dynamic focus and the need for excellent online representation in the digital age, APT has launched its new web site which improves on performance, has better information and easier accessibility and navigation.

Advanced Polymer Trading (APT), an international trading company specialising in the world wide trade of rubber, plastics and petrochemicals, is pleased to announce the launch of its new web site. Following a period of consultation and redesign, the new web site improves on performance, has better information and easier accessibility and navigation.

Improvements to the web site are on several fronts. The improved performance comes due to technical changes in the underlying software which powers the web site and simultaneously it offers APT greater flexibility for content management. The redesign has ensured that better and clearer information is available online to past, present an future customers as well as perspective investors or employees. One of the key emphasis of the new design is to ensure east navigation and accessibility. The majority of the site’s rich information can be found with just one or two clicks.

“A solid, accessible online presence is essential in today’s business environment” said Mr. Hamid Amiri, APT’s Managing Director. “APT has always been a flexible and leading edge company, this is reflected in our redesigned web site.”

2011 has been an excellent year for APT so far, in January APT entered into an agreement with Mitsui Chemicals Europe to market, sell and distribute Mitsui’s adhesive resin ADMER. ADMER adhesive resin is a functionally modified polyolefin that serves as a tie layer in multilayer applications including steel pipes. To kick-off the agreement Mitsui Chemicals Europe joined APT at ArabPlast 2011 and provided pre-sales support and technical advice on ADMER.

About Advanced Polymer Trading FZC

Advanced Polymer Trading FZC (APT) is an international trading company in plastic, rubber and chemicals serving a diverse range of industries including the automotive industry, packaging industry, construction, road and building material sectors, paint, resin and adhesive industries, pipe, medical, agriculture and the shoe & leather industries.

Advanced Polymer Trading FZC
19th Floor, Festival Tower
Dubai Festival City
Dubai – UAE

Tel: +971 4 293 2608
Fax: +971 4 293 2525

Website :

Press Contact:

ArtSec Group

Media & Publishing Division (
– +1 817 224 2231